DESCRIPTION: This is an application for a population-based, case-control
study of ovarian cancer in North Carolina. It proposes to conduct home
interviews and take blood from 700 new cases, identified through a rapid
reporting system, and 700 controls, identified through random digit
dialing (RDD) and Health Care Financing Administration (HCFA) files.
Tumor tissues will be tested for p53 mutations and for HER-2/neu
amplification: the first using immunohistochemical staining supplemented
by sequencing; and the second using FISH. Genomic DNA will be tested for
polymorphisms in the genes for TP53, H-Ras, CYP17 and epoxide hydrolase.
The general hypothesis is that ovarian cancer is a heterogeneous disease
caused by several different mutational pathways. The application proposes
to test this by analyzing subgroups of the data defined by tumors with or
without mutations in p53, different histologic types and different
polymorphisms. Published preliminary studies have already shown an
association with abnormal expression of p53 in ovarian tumors and
epidemiologic markers of ovulation.
Error Notice
The database may currently be offline for maintenance and should be operational soon. If not, we have been notified of this error and will be reviewing it shortly.
We apologize for the inconvenience.
- The DCCPS Team.